View in EDS

923MO First results from a phase I trial of SNV1521, a next generation, CNS-penetrant, PARP1-selective inhibitor in patients (pts) with molecularly selected advanced solid tumors.

Saved in:
Bibliographic Details
Title: 923MO First results from a phase I trial of SNV1521, a next generation, CNS-penetrant, PARP1-selective inhibitor in patients (pts) with molecularly selected advanced solid tumors.
Authors: Yap, T.A.1 (AUTHOR), Lemech, C.2 (AUTHOR), Voskoboynik, M.3 (AUTHOR), Millward, M.4 (AUTHOR), Hafez, M.5 (AUTHOR), Tam, L.6 (AUTHOR), Subbiah, V.7 (AUTHOR), Call, J.A.8 (AUTHOR), Zhou, Y.9 (AUTHOR), Terry, K.10 (AUTHOR), O'Hayer, K.10 (AUTHOR), Lorusso, P.M.11 (AUTHOR)
Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS603-S604. 2p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 189419305
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 923MO First results from a phase I trial of SNV1521, a next generation, CNS-penetrant, PARP1-selective inhibitor in patients (pts) with molecularly selected advanced solid tumors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Yap%2C+T%2EA%2E%22">Yap, T.A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lemech%2C+C%2E%22">Lemech, C.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Voskoboynik%2C+M%2E%22">Voskoboynik, M.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Millward%2C+M%2E%22">Millward, M.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hafez%2C+M%2E%22">Hafez, M.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tam%2C+L%2E%22">Tam, L.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Subbiah%2C+V%2E%22">Subbiah, V.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Call%2C+J%2EA%2E%22">Call, J.A.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+Y%2E%22">Zhou, Y.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Terry%2C+K%2E%22">Terry, K.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22O'Hayer%2C+K%2E%22">O'Hayer, K.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lorusso%2C+P%2EM%2E%22">Lorusso, P.M.</searchLink><relatesTo>11</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 2, Vol. 36, pS603-S604. 2p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189419305
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2025.08.1492
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: S603
    Titles:
      – TitleFull: 923MO First results from a phase I trial of SNV1521, a next generation, CNS-penetrant, PARP1-selective inhibitor in patients (pts) with molecularly selected advanced solid tumors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yap, T.A.
      – PersonEntity:
          Name:
            NameFull: Lemech, C.
      – PersonEntity:
          Name:
            NameFull: Voskoboynik, M.
      – PersonEntity:
          Name:
            NameFull: Millward, M.
      – PersonEntity:
          Name:
            NameFull: Hafez, M.
      – PersonEntity:
          Name:
            NameFull: Tam, L.
      – PersonEntity:
          Name:
            NameFull: Subbiah, V.
      – PersonEntity:
          Name:
            NameFull: Call, J.A.
      – PersonEntity:
          Name:
            NameFull: Zhou, Y.
      – PersonEntity:
          Name:
            NameFull: Terry, K.
      – PersonEntity:
          Name:
            NameFull: O'Hayer, K.
      – PersonEntity:
          Name:
            NameFull: Lorusso, P.M.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2025 Supplement 2
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 36
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1